These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 2544663

  • 1. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    Allday MJ, Crawford DH, Griffin BE.
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
    [Abstract] [Full Text] [Related]

  • 2. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG, Catovsky D, Crawford DH.
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ, Crawford DH, Thomas JA.
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD, Rowe M, Cadwallader K, Ricksten A, Gordon J, Wang F, Rymo L, Rickinson AB.
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM.
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ, Young LS, Calender A, Gregory CD, Rowe M, Lenoir GM, Rickinson AB.
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG, Crawford DH.
    Intervirology; 1994 Mar; 37(5):236-44. PubMed ID: 7698878
    [Abstract] [Full Text] [Related]

  • 12. Immortalizing genes of Epstein-Barr virus.
    Middleton T, Gahn TA, Martin JM, Sugden B.
    Adv Virus Res; 1991 Mar; 40():19-55. PubMed ID: 1659776
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
    Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G.
    J Virol; 1989 Jul; 63(7):3135-41. PubMed ID: 2470924
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.
    Sinclair AJ, Palmero I, Peters G, Farrell PJ.
    EMBO J; 1994 Jul 15; 13(14):3321-8. PubMed ID: 8045261
    [Abstract] [Full Text] [Related]

  • 18. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C, Haiss P, Grässer FA, Zimber-Strobl U, Mueller-Lantzsch N.
    J Gen Virol; 1994 Nov 15; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB.
    J Gen Virol; 1988 May 15; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [Abstract] [Full Text] [Related]

  • 20. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI.
    J Virol; 2006 Nov 15; 80(21):10700-11. PubMed ID: 16920819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.